Press release
ROHKEA® VR Therapy Achieves MDR Class IIa Certification, Marking Major Milestone in Digital Therapeutics for Chronic Pain
Newel Health announce that ROHKEA® VR Therapy has received MDR Class IIa certification as a medical device, paving the way for its European commercialization. This certification validates ROHKEA®'s intended use is to provide an automated intervention based on cognitive behavioral therapy to help patients overcome fear of movement caused by chronic musculoskeletal pain.ROHKEA® is originally developed by Finnish pharmaceutical company Orion. Newel Health has the exclusive global rights to develop, manufacture and commercialize ROHKEA®.
"This MDR certification is a significant milestone for Newel Health," said Ervin Ukaj, CEO at Newel Health. "It reflects the dedication and collaboration of our teams and our shared vision to improve the lives of people living with chronic pain. With this approval, we can now bring ROHKEA® to patients across Europe, offering a proven and accessible solution to help them regain confidence in their movement and improve their quality of life.
ROHKEA® is a novel virtual reality-based digital therapeutic that combines cognitive behavioral therapy with physical activation exercises in an immersive environment. Delivered through a 12-week program with a virtual mentor, it provides therapy for chronic musculoskeletal pain patients in their homes. The recent MDR Class IIa certification complements ROHKEA®'s clinical validation from the VIRPI study, which demonstrated significant reductions in fear of movement and marked improvements in Patient Clinical Global Impression of Change compared to placebo controls.
"ROHKEA®️, a virtual reality-based medical device software, shows how foundational scientific ideas can evolve also into novel digital opportunities to help the patients.," said Sammeli Liikkanen, Director of Digital Medicine at Orion Corporation. "We're pleased to see our development work culminate in this certification, enabling Newel Health to bring this important therapy to market."
"Cognitive behavioral therapy is a well-established first-line treatment for chronic pain management, but accessibility has been a persistent challenge," said Professor Christopher Eccleston, lead Clinical Advisor for the project. "ROHKEA® represents a breakthrough in pain treatment delivery - its automated, immersive approach allows clinicians to provide evidence-based therapy at scale, potentially transforming how pain management services are delivered to patients."
Newel Health plans to initially focus on healthcare systems and pain management clinics seeking evidence-based, scalable solutions for chronic pain management.
Media Contacts:
Gerry Chillè, CIO, Newel Health - gerry.chille@newel.health
About Newel Health Newel Health, a leader in digital health, develops advanced digital medicine and therapeutic solutions, emphasizing behavioural science and user-centred design to enhance patient care. The company's expertise in patient-centred healthcare drives strategic partnerships, enabling stakeholders to leverage its digital health solutions portfolio.
About Orion Corporation Orion is a globally operating Finnish pharmaceutical company and builder of well-being. The company develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients, with an extensive portfolio of proprietary and generic medicines and self-care products.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ROHKEA® VR Therapy Achieves MDR Class IIa Certification, Marking Major Milestone in Digital Therapeutics for Chronic Pain here
News-ID: 3852233 • Views: …
More Releases for ROHKEA®
Punch!® Software Releases Punch!CAD™ SharkCAD® & ViaCAD® 15
NOVATO, Calif., December 10, 2024 - Punch!® Software, a leading software developer of Home Design and CAD titles for over 25 years, today announced the release of new Windows and Mac versions of the SharkCAD® 15 and ViaCAD® 15 family of products.
This latest release encompasses a range of variants for the Windows and Macintosh platform: SharkCAD® Pro, SharkCAD®, ViaCAD® Pro, ViaCAD® 2D/3D, and ViaCAD® 2D.
Punch!CAD™ products continue to provide innovative…
Cherrywork® Accounts Payable Automation by Incture® Now Available on SAP® Sto …
Incture® today announced the availability of Cherrywork® Accounts Payable Automation for purchase on SAP® Store, the online marketplace for SAP and partner offerings. Cherrywork® Accounts Payable Automation is built on SAP Business Technology Platform (SAP BTP) to streamline end-to-end accounts payable operations, reduce accounting costs, and help increase cash flow for customers.
"Cherrywork Accounts Payable Automation is the hyperautomation solution to step up the source to pay process for our customers.…
Ultimate Chemicals® Featured in Manufacturing Marvels® on The Fox Business Net …
MOORE, OK., Oct. 8, 2021/ -- Ultimate Chemicals® Inc., an integrated manufacturer and supplier of chemicals and related services, is pleased to announce it will be showcased in a broadcast of Manufacturing Marvels® scheduled to air on October 14, 2021 at approximately 9:30-9:44 p.m. EST on The Fox Business Network® (FBN).
Ultimate Chemicals has created their products to help restore surfaces to their optimum surface capability. Non-destructive to the surfaces to…
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA
Sunera Technologies, Inc Joins SAP® PartnerEdge® Delivering SAP® S/4HANA and Intelligent Enterprise to Manufacturing, Consumer Products, Higher education, and research, Industrial machinery and components, Life sciences and Automotive Industries
Chicago, IL, June 10, 2020 – Sunera Technologies, Inc announced that it had joined the SAP® PartnerEdge® program as a Re-sell & Services partner, through which it will resell SAP solutions to midsize organizations in North America. Through this engagement, SuneraTech…
American Megatrends Announces AMIBIOS®8 & Aptio®4.x Support for the Intel® Xe …
ATLANTA, GEORGIA - American Megatrends (AMI) is pleased to announce that its AMIBIOS®8 & Aptio®4.x products feature support for the new Intel® Xeon® 5500 Platform.
The Intel® Xeon® 5500 platform combines the Intel® Xeon® Processor 5500 Series with the Intel® 5520 Chipset for embedded, storage, security and communications infrastructure applications in a wide range of form factors. There are four different processor options for this platform with seven year lifecycle support…
CNUX .NET Providers for DB2® Earns IBM® DB2® Data Server Certification
CNUX Technologies Inc. announced today that CNUX .NET Providers for DB2® - Standard and Web Service Edition have achieved "Ready for IBM DB2 Data Server Software" status. With this designation CNUX customers can be assured that CNUX .NET Providers interacts and operates seamlessly with IBM® DB2® software.
The "Ready for IBM DB2 Data Server Software" program is a process designed for independent software vendors (ISVs) and solution integrators to validate their…